theory clinical_25_0
imports Main

begin

typedecl entity
typedecl event

consts
  YAP :: "entity ⇒ bool"
  BetaCatenin :: "entity ⇒ bool"
  HepatoblastomaDevelopment :: "entity ⇒ bool"
  Cooperates :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Accompaniment :: "event ⇒ entity ⇒ bool"
  Induce :: "event ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  YAPSuppression :: "entity ⇒ bool"
  BetaCateninLevels :: "entity ⇒ bool"
  BetaCateninDependentGrowth :: "entity ⇒ bool"
  Reduces :: "event ⇒ bool"
  Inhibits :: "event ⇒ bool"
  YAPInhibitor :: "entity ⇒ bool"
  BetaCateninActivity :: "entity ⇒ bool"
  Effective :: "event ⇒ bool"
  Inhibiting :: "event ⇒ bool"

(* Explanation 1: YAP cooperates with β-catenin to induce Hepatoblastoma development. *)
axiomatization where
  explanation_1: "∃x y z e1 e2. YAP x ∧ BetaCatenin y ∧ HepatoblastomaDevelopment z ∧ Cooperates e1 ∧ Agent e1 x ∧ Accompaniment e1 y ∧ Induce e2 ∧ Agent e2 x ∧ Patient e2 z"

(* Explanation 2: YAP suppression reduces β-catenin levels and inhibits β-catenin dependent growth. *)
axiomatization where
  explanation_2: "∃x y z e1 e2. YAPSuppression x ∧ BetaCateninLevels y ∧ BetaCateninDependentGrowth z ∧ Reduces e1 ∧ Agent e1 x ∧ Patient e1 y ∧ Inhibits e2 ∧ Agent e2 x ∧ Patient e2 z"

theorem hypothesis:
  assumes asm: "YAPInhibitor x ∧ BetaCateninActivity y"
  (* Hypothesis: A YAP inhibitor may be effective in inhibiting β-catenin activity. *)
  shows "∃x y e1 e2. YAPInhibitor x ∧ BetaCateninActivity y ∧ Effective e1 ∧ Agent e1 x ∧ Inhibiting e2 ∧ Agent e2 x ∧ Patient e2 y"
proof -
  (* From the premise, we have known information about YAP inhibitor and β-catenin activity. *)
  from asm have "YAPInhibitor x ∧ BetaCateninActivity y" by blast
  (* Explanation 2 states that YAP suppression reduces β-catenin levels and inhibits β-catenin dependent growth. *)
  (* We have a derived implication that Implies(C, E), Implies(YAP is suppressed, β-catenin dependent growth is inhibited). *)
  (* If a YAP inhibitor acts similarly to YAP suppression, it may reduce β-catenin activity. *)
  (* Therefore, a YAP inhibitor may be effective in inhibiting β-catenin activity. *)
  then have "Effective e1 ∧ Agent e1 x ∧ Inhibiting e2 ∧ Agent e2 x ∧ Patient e2 y" sledgehammer
  then show ?thesis <ATP>
qed

end
